|1|Shape Changes of the Basal Ganglia and Thalamus in Alzheimer's Disease: A Three-Year Longitudinal Study. (24413620)
Cho H.... Seo S.W.
|2|Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings. (23269594)
Tabarki B.... Zuccoli G.
|3|Lateralized Cortical Involvement and Contralateral Parkinsonism without Basal Ganglia Involvement in Two Autopsy Cases of Corticobasal Syndrome-Alzheimer's Disease. (24326515)
Homma T.... Uchihara T.
|4|Diagnosis of moyamoya disease on magnetic resonance imaging: are flow voids in the basal ganglia an essential criterion for definitive diagnosis? (22939199)
Mikami T.... Mikuni N.
|5|Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases. (23742248)
Alfadhel M.... Al-Twaijri W.
|6|Biotin-Responsive Basal Ganglia Disease: A Treatable Differential Diagnosis of Leigh Syndrome. (24166474)
Distelmaier F.... Karenfort M.
|7|Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study. (23069680)
Georgiou-Karistianis N.... Egan G.F.
|8|Stress Induced Up-Regulation of Slc19a3 is Impaired in Biotin-Thiamine-Responsive Basal Ganglia Disease. (24372704)
SchAonzer A.... Hahn A.
|9|AP1S2 is mutated in X-linked Dandy-Walker malformation with intellectual disability, basal ganglia disease and seizures (Pettigrew syndrome). (23756445)
Cacciagli P.... Villard L.
|10|Basal Ganglia Neuronal Activity during Scanning Eye Movements in Parkinson's Disease. (24223158)
Sieger T.... Jech R.
|11|Unilateral Basal Ganglia Infarcts: a Red Flag for Ipsilateral Cranio-Cervical Arterial Occlusive Disease. A Report on Two Children with Moya-moya Disease. (24028882)
El Beltagi A.H.... Asbeutah A.
|12|Basal ganglia cellular pathology in multiple system atrophy, progressive supranuclear palsy and Parkinson disease. Can quantitative magnetic resonance spectroscopic imaging make the difference? (20561041)
Esterhammer R.... Seppi K.
|13|Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus. (19879254)
Hamaue N.... Aoki T.
|14|Adult-onset Alexander disease with typical "tadpole" brainstem atrophy and unusual bilateral basal ganglia involvement: a case report and review of the literature. (20359319)
Namekawa M.... Nakano I.
|15|Structural findings in the basal ganglia in genetically determined and idiopathic Parkinson's disease. (18823048)
Reetz K.... Binkofski F.
|16|The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases. (17178818)
Warren N.M.... Burn D.J.
|17|Stiff person syndrome (SPS), a basal ganglia disease? Striatal MRI lesions in a patient with SPS. (17507452)
Guardado SantervA!s P.L.... Huete Hurtado A.
|18|Biotin-responsive basal ganglia disease-linked mutations inhibit thiamine transport via hTHTR2: biotin is not a substrate for hTHTR2. (16790503)
Subramanian V.S.... Said H.M.
|19|Differential patterns of dopamine transporter loss in the basal ganglia of progressive supranuclear palsy and Parkinson's disease: analysis with [(123)I]IPT single photon emission computed tomography. (16473371)
Im J.H.... Lee M.C.
|20|Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. (17197367)
Mehler-Wex C.... Gerlach M.
|21|Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. (15871139)
Zeng W.-Q.... Gusella J.F.
|22|Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. (15911799)
Walter U.... Dressler D.
|23|Athymhormia and disorders of motivation in Basal Ganglia disease. (15616180)
|24|Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). (15596772)
Oliveira J.R.... Geschwind D.H.
|25|Neurokinin peptides and neurokinin receptors as potential therapeutic intervention targets of basal ganglia in the prevention and treatment of Parkinson's disease. (15011953)
Chen L.W.... Chan Y.S.
|26|Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease. (11884785)
Righini A.... Pezzoli G.
|27|Familial idiopathic basal ganglia calcification (Fahr's disease) without neurological, cognitive and psychiatric symptoms is not linked to the IBGC1 locus on chromosome 14q. (11810290)
Brodaty H.... Schofield P.R.
|28|Corticobasal degeneration syndrome with basal ganglia calcification: Fahr's disease as a corticobasal look-alike? (12112208)
Warren J.D.... Wood N.W.
|29|Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. (11438811)
Curtis A.R.... Burn J.
|30|Lesch-Nyhan disease and the basal ganglia. (10760551)
Visser J.E.... Jinnah H.A.
|31|The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. (10828533)
Glass M.... Faull R.L.
|32|Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). (10441584)
Geschwind D.H.... Stern J.M.
|33|PEP-19 immunohistochemistry defines the basal ganglia and associated structures in the adult human brain, and is dramatically reduced in Huntington's disease. (9697113)
Utal A.K.... Coleman P.D.
|34|Biotin-responsive basal ganglia disease: a novel entity. (9679779)
Ozand P.T.... Dabbagh O.
|35|Alternating paroxysmal dystonia and hemiplegia in childhood as a symptom of basal ganglia disease. (7561937)
Hart Y.M.... Farrell K.
|36|Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients. (7969897)
Fernandez A.... Marsden C.D.
|37|Clinical features of neuroleptic malignant syndrome in basal ganglia disease. Spontaneous presentation in a patient with Hallervorden-Spatz disease in the absence of neuroleptic drugs. (8322990)
Hayashi K.... Tanaka Y.
|38|Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease. (1656540)
Waeber C.... Palacios J.M.
|39|New X-linked mental retardation disorder with Dandy-Walker malformation, basal ganglia disease, and seizures. (2018058)
Pettigrew A.L.... Ledbetter D.H.
|40|Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease. (1835521)
Martinez-Mir M.I.... Palacios J.M.
|41|Psychiatric consequences of basal ganglia disease. (2259804)
|42|Neurotensin receptors in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study in basal ganglia. (1965015)
Chinaglia G.... Palacios J.M.
|43|Met-enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degeneration. (2192300)
Goto S.... Matsumoto S.
|44|Studies on neurotransmitter markers of the basal ganglia in Pick's disease, with special reference to dopamine reduction. (2450180)
Kanazawa I.... Nukina N.
|45|Technetium-99m HMPAO imaging in patients with basal ganglia disease. (2973362)
Smith F.W.... Besson J.A.
|46|Ventricular somatostatin-like immunoreactivity in patients with basal ganglia disease. (2864402)
Cramer H.... Ostertag C.
|47|Motor disorders in basal ganglia disease. (6715209)
|48|Sea-blue histiocytes, lymphocytic cytosomes, movement disorder and 59Fe-uptake in basal ganglia: Hallervorden-Spatz disease or ceroid storage disease with abnormal isotope scan? (6681873)
Swaiman K.F.... Siddiqui A.R.
|49|Paresis of vertical gaze in basal ganglia disease. (4538012)
Corin M.S.... BENDER M.B.
|50|Psychiatric syndromes in patients with organic brain disease; diseases of the basal ganglia. (20243408)
Brenner C.... MERRITT H.H.